Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 500298 | NSE Symbol : NATPEROXID | ISIN : INE585A01020 | Industry : Finance & Investments |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
01-May-2025	06-May-2025	Accounts	Naperol Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2025 inter alia to consider and approve the Audited Financial Results for the quarter and financial year ended March 31 2025. This is to inform you that the Board of Directors of Naperol Investments Limited (formerly known as National Peroxide Limited) ('the Company') at its meeting held today i.e., on May 06, 2025, had inter-alia considered and approved the following: 1. Statement of Audited Financial Results of the Company for the quarter and financial year ended March 31, 2025. 2. Appointment of M/s. Parikh & Associates, Practicing Company Secretaries as Secretarial Auditors of the Company (As per BSE Announcement Dated on 06/05/2025)
18-Mar-2025	21-Mar-2025	Interim Dividend	Naperol Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/03/2025 inter alia to consider and approve to consider the declaration of an interim dividend if any for the financial year 2024-25. We wish to inform the Exchange that the Board of Directors at its meeting held today, i.e. March 21, 2025, have considered and declared interim dividend for the financial year 2024-25 of Rs. 9.00/- per equity share i.e. 90% of face value of Rs.10/- per equity share. Further, the Board of Directors have fixed Thursday, March 27, 2025, as the Record Date to determine the eligibility of shareholders to receive the aforesaid interim dividend (As Per BSE Announcement Dated on 21.03.2025)
20-Jan-2025	23-Jan-2025	Quarterly Results	Naperol Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31, 2024 The Board of Directors of Naperol Investments Limited at their meeting held today i.e., on January 23, 2025, had inter-alia considered and approved the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2024. The Company has informed the Exchange about revised Outcome of the Board Meeting. (As Per BSE Announcement Dated on: 23/01/2025)
24-Oct-2024	29-Oct-2024	Quarterly Results	Naperol Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 inter alia to consider and approve Unaudited Financial Results for the quarter and half year ended on September 30 2024. This is to inform that the Board of Directors of Naperol Investments Limited (fka National Peroxide Limited) ('the Company') at their meeting held today i.e., on October 29, 2024, had inter-alia considered and approved the unaudited financial results of the Company for the quarter and half-year ended September 30, 2024 and approved appointment of Company Secretary & Compliance Officer of the Company. (As Per BSE Announcement dated on 29.10.2024)
24-Jul-2024	31-Jul-2024	Quarterly Results	Naperol Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2024 inter alia to consider and approve Board Meeting of Naperol Investments Limited (formerly known as National Peroxide Limited) is scheduled to be held on Wednesday July 31 2024 inter-alia to consider and approve the Unaudited Financial Results for the quarter ended June 30 2024. Outcome of Board Meeting 1. Unaudited Financial Results of the Company for the quarter ended June 30, 2024. The said Unaudited Financial Results and the Limited Review Report for the quarter ended June 30, 2024 are enclosed; The Unaudited Financial Results are being published in newspapers as required under the provisions of Listing Regulations. 2. Book Closure: The Register of Members and the Share Transfer Books of the Company will be closed for the purpose of Annual General Meeting from August 21, 2024 to August 27, 2024, both days inclusive. 3. Annual General Meeting: The Board decided that the 70th Annual General Meeting of the Company would be held on August 27, 2024 at 2.00 p.m. through video conference/other audio visual means. 4. Appointment, Resignation & Cessation of Director & Key Managerial Personnel(s) a. Appointment of Mr. Keki Manchersha Elavia (DIN: 00003940) as an Additional Director designated as Non-Executive Independent Director, not liable to retire by rotation, for a tenure of 5 (five) consecutive years commencing from July 31, 2024 to July 30, 2029 as recommended by the Nomination and Remuneration Committee which shall be subject to approval of the shareholders of the Company. b. Appointment of Mr. Deepak Kumar as the Chief Financial Officer and Chief Risk Officer of the Company with effect from July 31, 2024 as recommended by the Nomination and Remuneration Committee and based on approval of the Audit Committee. c. Noting of cessation of Directorship of Mr. Rajesh Kumar Batra (DIN: 00020764), onExecutive Independent Director of the Company, upon completion of second term of 5 years effective closure of business hours of August 10, 2024 in compliance with the provisions of Section 149(11) of the Companies Act, 2013. The Board placed on record its appreciation for the invaluable contributions made by Mr. Rajesh Kumar Batra during his tenure as the Non-Executive Independent Director of the Company. d. Noting of resignation by Mr. Arpit Maheshwari (ACS: 42396) vide his resignation letter dated July 31, 2024 from the post of Company Secretary and Compliance Officer of the Company to pursue opportunity outside Wadia group. His last working day with the Organisation will be September 2, 2024. In terms of SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 read with Regulation 30 of the (Listing Obligations and Disclosure Requirements) Regulations, 2015, the information required in respect of item no. 4 is given in the Annexure - I'. Appointment of Chief Financial Officer and Resignation by Company Secretary & Compliance Officer of the Company (As Per BSE Announcement Dated on 31.07.2024)
09-May-2024	09-May-2024	Change in Directors	Announcement under Regulation 30 (LODR) - Change in Directorate
01-May-2024	08-May-2024	Quarterly Results	Naperol Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2024 inter alia to consider and approve the Audited Financial Results for the quarter and financial year ended March 31 2024. Audited Financial Results for the quarter and financial year ended March 31, 2024. (As Per BSE Announcement Dated on: 08/05/2024)
31-Jan-2024	07-Feb-2024	Quarterly Results	Naperol Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2024 inter alia to consider and approve the Unaudited Financial Results for the quarter and nine months ended on 31st December 2023. Outcome of Board Meeting (As Per BSE Announcement dated on 07.02.2024)
30-Oct-2023	06-Nov-2023	Quarterly Results	NATIONAL PEROXIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30 2023. NATIONAL PEROXIDE LIMITED has informed BSE about Board Meeting to be held on 06 Nov 2023 to consider financial statements for the period ended September 2023. Financial results. This is to inform you that the Board of Directors of National Peroxide Limited (''the Company'') at their meeting held today i.e., November 6, 2023, have considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023. This is to inform you that the Board of Directors of National Peroxide Limited (''the Company'') at their meeting held on November 6, 2023 have considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023. (As Per BSE Announcement dated on 06.11.2023)
11-Oct-2023	20-Oct-2023	Accounts	NATIONAL PEROXIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2023 inter alia to consider and approve the revised Audited Financial Statements for the financial year ended March 31 2023 after giving effect to the Composite Scheme of Arrangement and to recommend dividend if any for the financial year ended March 31 2023. The Board Meeting to be held on 17/10/2023 has been revised to 20/10/2023 The Board Meeting to be held on 17/10/2023 has been revised to 20/10/2023 (As Per BSE Announcement dated on 14.10.2023) Outcome of Board Meeting (As per BSE Announcement Dated on 20/10/2023)
02-Aug-2023	08-Aug-2023	Quarterly Results	NATIONAL PEROXIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we wish to inform you that a meeting of the Board of Directors of National Peroxide Limited is scheduled to be held on Tuesday August 8 2023 inter-alia to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2023. Unaudited Financial Results for the Quarter ended June 30, 2023. Shifting of Head Office from C-1, Wadia International Centre, Pandurang Budhkar Marg, Worli, Mumbai - 400 025 to The Island City Center (ICC), G.D. Ambekar Marg, Dadar (East), Mumbai - 400 014 with effect from August 8, 2023. (As Per BSE Announcement Dated on 08.08.2023)
16-May-2023	23-May-2023	Quarterly Results	NATIONAL PEROXIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we wish to inform you that a meeting of the Board of Directors of National Peroxide Limited is scheduled to be held on Tuesday May 23 2023 inter-alia to consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31 2023 and to recommend dividend if any for the financial year ended March 31 2023. This is to inform you that the Board of Directors of National Peroxide Limited ('the Company') at their meeting held today i.e., May 23, 2023, have considered and approved the Statement of Standalone and Consolidated Audited Financial Results for the quarter and financial year ended March 31, 2023. A copy of the said results and audit report is enclosed. (As Per BSE Announcement Dated on 23/05/2023)
07-Feb-2023	14-Feb-2023	Quarterly Results	NATIONAL PEROXIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended on December 31 2022. This is to inform you that the Board of Directors of National Peroxide Limited ('the Company') at their meeting held today i.e., February 14, 2023, have considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2022. (As per BSE Announcement Dated on 14/02/2023)
03-Nov-2022	10-Nov-2022	Quarterly Results	NATIONAL PEROXIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30 2022. This is to inform you that the Board of Directors of National Peroxide Limited ('the Company') at their meeting held today i.e., November 10, 2022, have considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2022. (As per BSE Announcement Dated on 10/11/2022)
20-Sep-2022	20-Sep-2022	Scheme of Arrangement	Outcome of Board Meeting held on Tuesday, September 20, 2022 - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

1 2

LOGIN HERE

Naperol Investments Ltd

Board Meeting